Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $917.50 | 40 | 90.2% |
| Education | $99.99 | 1 | 9.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $237.55 | 12 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $132.24 | 2 | $0 (2024) |
| ConvaTec Inc. | $93.83 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $56.49 | 2 | $0 (2024) |
| Medtronic, Inc. | $49.21 | 1 | $0 (2021) |
| GENZYME CORPORATION | $48.90 | 2 | $0 (2024) |
| SI-BONE, Inc. | $44.60 | 1 | $0 (2019) |
| Celgene Corporation | $38.01 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $37.73 | 1 | $0 (2024) |
| LEO Pharma Inc. | $37.04 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $525.55 | 17 | SUN PHARMACEUTICAL INDUSTRIES INC. ($132.24) |
| 2023 | $76.34 | 3 | ABBVIE INC. ($54.38) |
| 2022 | $13.35 | 1 | ABBVIE INC. ($13.35) |
| 2021 | $49.21 | 1 | Medtronic, Inc. ($49.21) |
| 2019 | $120.21 | 4 | SI-BONE, Inc. ($44.60) |
| 2017 | $232.83 | 15 | AbbVie, Inc. ($68.70) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $36.62 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $33.90 | General |
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Dermatology | ||||||
| 07/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: DERMATOLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 04/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/19/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 02/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $99.99 | General |
| 02/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: Dermatology | ||||||
| 09/13/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: EYE CARE | ||||||
| 08/17/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: Immunology | ||||||
| 07/12/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: EYE CARE | ||||||
| 11/07/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2021 | Medtronic, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $49.21 | General |
| Category: EndoVenous Therapies | ||||||
| 09/06/2019 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | In-kind items and services | $44.60 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 06/10/2019 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| 05/16/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,211 | 1,790 | $553,374 | $217,070 |
| 2022 | 25 | 1,009 | 1,448 | $723,329 | $286,826 |
| 2021 | 31 | 1,434 | 2,137 | $801,730 | $320,381 |
| 2020 | 24 | 1,252 | 1,917 | $686,217 | $270,073 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 124 | 169 | $181,785 | $77,952 | 42.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 78 | 107 | $69,645 | $32,752 | 47.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 36 | 39 | $39,363 | $16,769 | 42.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 66 | 77 | $57,998 | $14,607 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 132 | 166 | $23,998 | $10,944 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 105 | $21,503 | $9,312 | 43.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 43 | 44 | $29,878 | $7,897 | 26.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 101 | 125 | $19,998 | $6,974 | 34.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 70 | 81 | $14,460 | $6,088 | 42.1% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 14 | 16 | $9,981 | $4,452 | 44.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 21 | 21 | $13,267 | $4,395 | 33.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 99 | 133 | $14,136 | $4,010 | 28.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $9,873 | $3,952 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $7,491 | $3,111 | 41.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 80 | $6,442 | $2,942 | 45.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 16 | $7,720 | $2,360 | 30.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 57 | $5,116 | $2,130 | 41.6% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $8,724 | $2,072 | 23.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 62 | 368 | $3,834 | $1,716 | 44.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 35 | 35 | $4,017 | $1,270 | 31.6% |
| 69100 | Biopsy of ear | Office | 2023 | 12 | 16 | $2,449 | $762.20 | 31.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 16 | 18 | $1,629 | $579.06 | 35.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 23 | $67.62 | $20.12 | 29.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 205 | 260 | $271,329 | $114,033 | 42.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 122 | 178 | $114,651 | $55,327 | 48.3% |
About Dr. Laurel Leithauser, M.D
Dr. Laurel Leithauser, M.D is a MOHS-Micrographic Surgery healthcare provider based in Traverse City, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1912132945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laurel Leithauser, M.D has received a total of $1,017 in payments from pharmaceutical and medical device companies, with $525.55 received in 2024. These payments were reported across 41 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($917.50).
As a Medicare-enrolled provider, Leithauser has provided services to 4,906 Medicare beneficiaries, totaling 7,292 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Traverse City, MI
- Active Since 05/19/2009
- Last Updated 01/17/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1912132945
Products in Payments
- INNOVAMATRIX AC (Device) $93.83
- DUPIXENT (Biological) $69.39
- SPEVIGO (Drug) $56.49
- RINVOQ (Biological) $55.74
- DURYSTA (Drug) $54.38
- Humira (Biological) $53.15
- VenaSeal (Device) $49.21
- SKYRIZI (Biological) $45.38
- iFuse Implant (Device) $44.60
- EUCRISA (Drug) $33.48
- ILUMYA (Biological) $32.25
- Tremfya (Drug) $30.63
- Enbrel (Biological) $24.05
- ADBRY (Biological) $22.30
- Sotyktu (Drug) $21.96
- COSENTYX (Biological) $21.47
- Cimzia (Drug) $20.88
- DUPIXENT (Drug) $17.24
- Zoryve (Drug) $16.28
- TALTZ (Drug) $15.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.